Current Perspectives of Oxidative Stress and its Measurement in Chronic Obstructive Pulmonary Disease

REFERENCES

• Pauling L, Robinson AB, Teranishi R, Cary P. Quantitative analysis or urine vapor and breath by gas-liquid partition chromatography. Proc Natl Acad Sci USA 1971; 68:2374–2376.
   PubMed Web of Science ®Google Scholar
• Lopez AD, Murray CC. The global burden of disease, 1990–2020. Nat Med 1998; 4:1241–1243.
   PubMed Web of Science ®Google Scholar
• Barnes PJ. Immunology of asthma and chronic obstructive pulmonary disease. Nat Rev Immunol 2008; 8:183–192.
   PubMed Web of Science ®Google Scholar
• Joppa P, Petrasova D, Stancak B, Dorkova Z, Tkacova R. Oxidative stress in patients with COPD and pulmonary hypertension. Wien Klin Wochenschr 2007; 119:428–434.
   PubMed Web of Science ®Google Scholar
• Daga MK, Chhabra R, Sharma B, Mishra TK. Effects of exogenous vitamin E supplementation on the levels of oxidants and antioxidants in chronic obstructive pulmonary disease. J Biosci 2003; 28:7–11.
   PubMed Web of Science ®Google Scholar
• Gessner C, Scheibe R, Wotzel M, Hammerschmidt S, Kuhn H, Engelmann L, Hoheisel G, Gillisen A, Sack Ulrich, Wirtz H. Exhaled breath condensate cytokine patterns in chronic obstructive pulmonary disease. Respir Med 2005; 99:1229–1240.
   PubMed Web of Science ®Google Scholar
• Drost EM, Skwarski KM, Sauleda J, Soler N, Roca J, Agusti A, MacNee W. Oxidative stress and airway inflammation in severe exacerbations of COPD. Thorax 2005; 60:293–300.
   PubMed Web of Science ®Google Scholar
• Behrendt CE. Mild and moderate-to-severe COPD in nonsmokers: distinct demographic profiles. Chest 2005; 128:1239–1244.
   PubMed Web of Science ®Google Scholar
• Birring SS, Brightling CE, Bradding P, Entwisle JJ, Vara DD, Grigg J, Wardlaw AJ, Pavord ID. Clinical, radiologic, and induced sputum features of chronic obstructive pulmonary disease in nonsmokers: a descriptive study. Am J Respir Crit Care Med 2002; 166(8):1078–1083.
   PubMed Web of Science ®Google Scholar
• Salvi SS, Barnes PJ. Chronic obstructive pulmonary disease in non-smokers. Lancet 2009; 374(9691):733–743.
   PubMed Web of Science ®Google Scholar
• Schafer FQ, Buettner GR. Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Radic Biol Med 2001; 30(11):1191–1212.
   PubMed Web of Science ®Google Scholar
• Halliwell, Barry B, Poulsen, Henrik E. Cigarette smoke and oxidative stress. Berlin: Springer, 2006.
   Google Scholar
• Hunninghake GW, Crystal RG. Cigarette smoking and lung destruction: accumulation of neutrophils in the lungs of cigarette smokers. Am Rev Respir Dis 1983; 128(5):833–838.
   PubMed Web of Science ®Google Scholar
• van Der Toorn M, Smit-de Vries MP, Slebos DJ, de Bruin HG, Abello N, van Oosterhout AJ, Bischoff R, Kauffman HF. Cigarette smoke irreversibly modifies glutathione in airway epithelial cells. Am J Physiol Lung Cell Mol Physiol 2007; 293(5):L1156–L1162.
   PubMed Web of Science ®Google Scholar
• Foronjy R, Alison W, D’Aarmiento J. The pharmokinetic limitations of antioxidant treatment of COPD. Pulm Pharmacol Ther 2008; 21(2):370–379.
   PubMed Web of Science ®Google Scholar
• Stockley RA. Neutrophils and the pathogenesis of COPD. Chest 2002; 121(5 suppl):151S–155S.
   PubMed Web of Science ®Google Scholar
• Barnes PJ. Alveolar macrophages as orchestrator of COPD. J COPD 2004; 1(1):59–70.
   PubMedGoogle Scholar
• Bhowmik A, Seemungal TA, Sapsford RJ, Wedzicha JA. Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations. Thorax 2000; 55:114–120.
   PubMed Web of Science ®Google Scholar
• Paredi P, Kharitonov SA, Leak D, Ward S, Cramer D, Barnes PJ. Exhaled ethane, a marker of lipid peroxidation, is elevated in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000; 162:369–373.
   PubMed Web of Science ®Google Scholar
• Tomita K, Barnes PJ, Adcock IM. The effect of oxidative stress on histone acetylation and IL-8 release. Biochem Biophys Res Commun 2003; 301(2):572–577.
   PubMed Web of Science ®Google Scholar
• Barnes PJ. Chronic obstructive pulmonary disease. N Engl J Med 2000; 343(4):269–280.
   PubMed Web of Science ®Google Scholar
• Rahman I. Oxidative stress, chromatin remodeling and gene transcription in inflammation and chronic lung disease. J Biochem Mol Biol 2003; 36(1):95–109.
   PubMedGoogle Scholar
• Rajendrasozhan S, Yao H, Rahman I. Current perspective on role of chromatin modifications and deacetylases in lung inflammation in COPD. J COPD 2009; 6(4):291–297.
   PubMedGoogle Scholar
• Feldman C, Anderson R, Kanthakumar K, Vargas A, Coles PJ, Wilson R. Oxidant-mediated ciliary dystrunction in human respiratory epithelium. Free Radic Biol Med 1994; 17(1):1–10.
   PubMed Web of Science ®Google Scholar
• Wright DT, Fischer BM, Li C, Rochelle LG, Akley NJ, Adler KB. Oxidant stress stimulates mucin secretion and PLC in airway epithelium via a nitric oxide-dependent mechanism. Am J Physiol 1996; 271(5 pt 1):L854–L861.
   PubMed Web of Science ®Google Scholar
• Kim YD, Jeon JY, Woo HJ, Lee JC, Chung JH, Song SY, Yoon SK, Baek SH. Interleukin-1β induces MUC2 gene expression and mucin secretion via activation of PKC-MEK/ERK, and PL3K in human airway epithelial cells. J Korean Med Sci 2002; 17:765–771.
   Google Scholar
• Levine SJ, Larivee P, Logun C, Angus CW, Ognibene FP, Shelhamer JH. Tumor necrosis factor –α induces mucin hyupersecretion and MUC2 gene expression by human airway epithelial cells. Am J Respir Cell Mol Biol 1995; 12:196–204.
   PubMed Web of Science ®Google Scholar
• Yoon JH, Kim KS, Kim HU, Linton JA, Lee JG. Effects of TNF-α and IL-1β on mucin, lysozyme, IL-6 and IL-8 in passage-2 normal human nasal epithelial cells. Acta Otolaryngol 1999; 119:905–910.
   PubMed Web of Science ®Google Scholar
• Li JD, Dohrman AF, Gallup M, Miyata S, Gum JR, Kim YS, Nadel JA, Prince A, Basbaum CB. Transcriptional activation of mucin by pseudomonas aeruginosa lipopolysacchirde in the pathogenesis of cystic fibrosis lung disease. Proc Natl Acad Sci USA 1997; 94:967–972.
   PubMed Web of Science ®Google Scholar
• Demedts IK, Demoor T, Bracke KR, Joos GF, Brusselle GG. Role of apoptosis in the pathogenesis of COPD and pulmonary emphysema. Respir Res 2006; 7:53–62.
   PubMed Web of Science ®Google Scholar
• Anwar S, Whyte MKB. Implications of apoptotic cell death of esident and recruited cells in COPD. J COPD 2008; 5(3):143–145.
   PubMedGoogle Scholar
• Segura-Valdez L, Pardo A, Gaxiola M, Uhal BD, Becerril C, Selman M. Upregulation of gelatinases A and B, collagenases 1 and 2, and increased parenchymal cell death in COPD. Chest 2000; 117:684–694.
   PubMed Web of Science ®Google Scholar
• Imai K, Mercer BA, Schulman LL, Sonett JR, D’Armiento JM. Correlation of lung surface area to apoptosis and proliferation in human emphysema. Eur Res J 2005; 25:250–258.
   PubMed Web of Science ®Google Scholar
• Yokohori N, Aoshiba K, Nagai A. Increased levels of cell death and proliferation in alveolar wall cells in patients with pulmonary emphysema. Chest 2004; 125:626–632.
   PubMed Web of Science ®Google Scholar
• Hodge S, Hodge G, Holmes M, Reynolds PN. Apoptosis in COPD. Cur Resp Med Rev 2005; 1:33–41.
   Google Scholar
• Park JW, Ryter SW, Choi AMK. Functional significance of apoptosis in chronic obstructive pulmonary disease. J COPD 2007; 4(4):347–353.
   PubMedGoogle Scholar
• Fabbri LM, Romagnoli M, Corbetta L, Casoni G, Busljetic K, Turato G, Ligabue G, Ciaccia A, Saetta M, Papi A. Differences in airway inflammation in patients with fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease. Am J Respir Care Med 2003; 167(3):418–424.
   PubMed Web of Science ®Google Scholar
• Di Stefano A, Capelli A, Lusuardi M, Balbo P, Vecchio C, Maestrelli P, Mapp CE, Fabbri LM, Donner CF, Saetta M. Severity of airflow limitation is associated with severity of airway inflammation in smokers. Am J Respir Crit Care Med 1998; 158(4):1277–1285.
   PubMed Web of Science ®Google Scholar
• Bowler RP, Nicks M, Tran K, Tanner G, Cang LY, Young SK, Worthen GS. Extracellular superoxide dismutase attenuates lipopolysaccharide-induced neutrophilic inflammation. Amer J Respir Cell Mol Biol 2004; 31:432–439.
   PubMed Web of Science ®Google Scholar
• Pryor WA, Stone K. Oxidants in cigarette smoke: radicals, hydrogen peroxide, peroxynitrate, peroxynitrite. Annals NY Aca Sci 1993; 686:12–27.
   PubMed Web of Science ®Google Scholar
• Fireman E, Shtark M, Priel IE, Shiner R, Mor R, Kivity S, Fireman Z. Hydrogen peroxide in exhaled breath condensate (EBC) vs eosinophil count in induced sputum (IS) in parenchymal vs airways lung disease. Inflammation 2007; 30:44–51.
   PubMed Web of Science ®Google Scholar
• Chan HP, Tran V, Lewis C, Thomas PS. Elevated levels of oxidative stress markers in exhaled breath condensate. J Thorac Oncol 2009; 4(2):172–178.
   PubMed Web of Science ®Google Scholar
• Vaughan J, Ngamtrakulpanit L, Pajewski TN, Turner R, Nguyen TA, Smith A, Urban P, Hom S, Gaston B, Hunt J. Exhaled breath condensate pH is a robust and reproducible assay of airway acidity. Eur Res J 2003; 22:889–894.
   PubMed Web of Science ®Google Scholar
• Mulkey DK, Henderson RA, Ritucci NA, Putnam RW, Dean JB. Oxidative stress decreases pHi and Na+/H+ exchange and increases excitability of solitary complex neurons from rat brain slices. Am J Physiol Cell Physiol 2004; 286:C940–C951.
   PubMed Web of Science ®Google Scholar
• Kostikas K, Papatheodorou G, Ganas K, Psathakis K, Panagou P, Loukides S. pH in expired breath condensate of patients with inflammatory airway disease. Am J Respir Crit Care Med 2002; 165:1364–1370.
   PubMed Web of Science ®Google Scholar
• Pradico D, Lawson JA, Rokach J, FitzGerald GA. The isoprostanes in biology and medicine. Trends Endocrinol Metab 2001; 12:243–247.
   PubMed Web of Science ®Google Scholar
• Makris D, Paraskakis E, Korakas P, Karagiannakis E, Sourvinos G, Siafakas NM, Tzanakis N. Exhaled breath condensate 8-isoprostane, clinical parameters, radiological indices and airway inflammation in COPD. Respiration 2008; 72(2):138–144.
   Google Scholar
• Isik B, Isk SR, Yolacan H, Isik MR. Serum malonyldialdehyde and paraoxonase level in chronic obstructive pulmonary disease. Turk Res J 2005; 6:1.
   Google Scholar
• Calikoglu M, Unlu A, Tamer L, Ercan B, Bugdayci R, Atik U. The levels of serum vitamin C, malonyldialdehyde and erythrocyte reduced glutathione in chronic obstructive pulmonary disease and in healthy smokers. Clin Chem Lab Med 2002; 40:10.
   Google Scholar
• Balint B, Donnelly E, Hanazawa T, Kharitonov SA, Barnes PJ. Increased nitric oxide metabolites in exhaled breath condensate after exposure to tobacco smoke. Thorax 2001; 56:456–461.
   PubMed Web of Science ®Google Scholar
• Kharitonov SA, Barnes PJ. Nitric oxide, nitrotyrosine, and nitric oxide modulators in asthma and chronic obstructive pulmonary disease. Curr Allergy Asthma Rep 2003; 3:121–129.
   Google Scholar
• Osoata G, Hanazawa T, Brindicci C, Ito M, Barnes PJ, Kharitonov S, Ito K. Peroxynitrite elevation in exhaled breath condensate of COPD and its inhibition by fudosteine. Chest 2009; 135:1513–1520.
   PubMed Web of Science ®Google Scholar
• Montuschi P, Kharitonov SA, Barnes PJ. Exhaled carbon monoxide and nitric oxide in COPD. Chest 2001; 120(2):496–501.
   PubMed Web of Science ®Google Scholar
• Brindicci C, Ito K, Resta O, Pride NB, Barnes PJ, Kharitono SA. Exhaled nitric oxide from lung periphery is increased in COPD. Eur Respir J 2005; 26:52–59.
   PubMed Web of Science ®Google Scholar
• Ansarin K, Chatkin JM, Ferreira IM, Gutierrez CA, Zamel N, Chapman KR. Exhaled nitric oxide in chronic obstructive pulmonary disease: relationship to pulmonary function. Eur Respir J 2001; 17:934–938.
   PubMed Web of Science ®Google Scholar
• Ji Y, Neverova I, Van Eyk JE, Bennett BM. Nitration of tyrosine 92 mediates the activation of rat microsomal glutathione S-transferase by peroxynitrite. J Biol Chem 2006; 281:1986–1991.
   PubMed Web of Science ®Google Scholar
• Balint B, Kharitonov SA, Hanazawa T, Donnelly LE, Shah PL, Hodson ME, Barnes PJ. Increased introtyrosine in exhaled breath condensate in cystic fibrosis. Eur Res J 2001; 17:1201–1207.
   PubMed Web of Science ®Google Scholar
• Ueshima K, Minakata Y, Sugiura H, Yanagisawa S, Ichikawa T, Akamatsu K, Hirano T, Nakanishi M, Matsunaga K, Yamagata T, Ichinose M. The influence of free 3-nitrotyrosine and saliva on the quantitative analysis of protein-bound 3-nitrotyrosine in sputum. Anal Chem Insights 2007; 2:1–7.
   PubMedGoogle Scholar
• Ricciardolo FL, Caramori G, Ito K, Capelli A, Brun P, Abatangelo G, Papi A, Chung KF, Adcock I, Barnes PJ, Donner CF, Rossi A, Di Stefano A. Nitrosative stress in the bronchial mucosa of severe chronic obstructive pulmonary disease. J Allergy Clin Immunol 2005; 116(5):1028–1035.
   PubMed Web of Science ®Google Scholar
• Wung BS, Cheng JJ, Hsieh HJ, Shyy YJ, Wang DL. Cyclic strain-induced monocyte chemotactic protein-1 gene expression in endothelial cells involves reactive oxygen species activation of activator protein 1. Circ Res 1997; 8:1–7.
   Google Scholar
• Carpagnano GE, Kharitonov SA, Foschino-Barbaro MP, Resta O, Garmiccioni E, Barnes PJ. Increased inflammatory markers in the exhaled breath condensate of cigarette smokers. Eur Res J 2003; 21:589–593.
   PubMed Web of Science ®Google Scholar
• Montuschi P, Kharitonov S, Ciabattoni G, Barnes PJ. Exhaled leukotrienes and prostaglandins in COPD. Thorax 2003; 58(7):585–588.
   PubMed Web of Science ®Google Scholar
• Scheideler L, Manke HG, Schwulera U, Inacker O, Hammerle H. Detection of nonvolatile macromolecules in breath: a possible diagonstic tool? Am Rev Respir Dis 1993; 148:778–784.
   Google Scholar
• Cunningham S, McColm JR, Ho LP, Greening AP, Marshall TG. Measurement of inflammatory markers in the breath condensate of children with cystic fibrosis. Eur Res J 2000; 15:955–957.
   PubMed Web of Science ®Google Scholar
• Cao WQ, Duan YX. Breath analysis: potential for clinical diagnosis and exposure assessment. Clin Chem 2006; 52(5):800–811.
   PubMed Web of Science ®Google Scholar
• Rovina N, Papapetropoulos A, Kollintza A, Michailidou M, Simoes D, Roussos C, Gratziou C. Vascular endothelial growth factor: an angiogenic factor reflecting airway inflammation in healthy smokers and in patients with bronchitis type of chornic obstructive pulmonary disease. Respir Res 2007; 8:53–60.
   PubMed Web of Science ®Google Scholar
• Garey KW, Neuhauser MM, Robbins RA, Danziger LH, Rubinstein I. Markers of inflammation in exhaled breath condensate of young healthy smokers. Chest 2004; 125(1):22–25.
   PubMed Web of Science ®Google Scholar
• Sapey E, Bayley D, Ahmad A, Newbold P, Snell N, Stockley RA. Inter-relationships between inflammatory markers in patients with stable COPD with bronchitis: intra-patient and inter-patient variability. Thorax 2007; 63:493–499.
   PubMed Web of Science ®Google Scholar
• Moore B, Murphy RF, Agrawal DK. Interaction of TGF-beta with immune cells in airways disease. Curr Mol Med 2008; 8(5):427–436.
   PubMed Web of Science ®Google Scholar
• Duvernelle C, Freund V, Frossard N. Transforming growth factor-beta and its role in asthma. Pulm Pharmacol Ther 2003; 16(4):181–196.
   PubMed Web of Science ®Google Scholar
• Van Berkel JJBN, Dallinga JW, Moller GM, Godschalk RWL, Moonen EJ, Wouters EFM, Van Schooten FJ. A profile of volatile organic compounds in breath discriminates COPD patients from controls. Respir Med 2009; 104(4):557–563.
   PubMed Web of Science ®Google Scholar
• Ibrahim B, Basanta M, Dockry R, Tal-Singer R, Douce D, Woodcock AA, Singh D, Fowler SJ. Exhaled volatile organic compounds as potential biomarkers in chronic obstructive pulmonary disease. Amer J Respir Crit Care Med 2010; 181:A1012.
   PubMedGoogle Scholar
• Kanazawa H, Yoshikawa J. Elevated oxidative stress and reciprocal reduction of vascular endothelial growth factor levels with severity of COPD. Chest 2005; 128:3191–3197.
   PubMed Web of Science ®Google Scholar
• Kasahara Y, Tuder RM, Cool CD, Lynch DA, Flores SC, Voelkel NF. Endothelial cell death and decreased expression of vascular endothelial growth factor and vascular endothelial growth factor receptor 2 in emphysema. Am J Respir Crit Care Med 2001; 163:737–744.
   PubMed Web of Science ®Google Scholar
• Sakao S, Tatsumi K, Hashimoto T, Igari H, Shino Y, Shirasawa H, Kuriyama T. Vascular endothelial growth actor and the risk of smoking-related COPD. Chest 2003; 124:323–327.
   PubMed Web of Science ®Google Scholar
• Day BJ. Antioxidants as potential therapeutics for lung fibrosis. Antioxid Redox Signal 2008; 10(2):355–370.
   PubMed Web of Science ®Google Scholar
• MacNee W. Treatment of stable COPD: antioxidants. Eur Respir Rev 2005; 14:12–22.
   Google Scholar
• Oberley-Deegan RE, Regan EA, Kinnula VL, Crapo JD. Extracellular superoxide dismutase and risk of COPD. J COPD 2009; 6(4):307–312.
   PubMedGoogle Scholar
• Larsen GL, White CW, Takeda K, Loader JE, Nguyen DD, Joetham A, Groner Y, Gelfand EW. Mice that overexpress Cu/Zn superoxide dismutase are resistant to allergen-induced changes in airway control. Am J Physiol Lung Cell Mol Physiol 2000; 279(2):L350–L359.
   PubMed Web of Science ®Google Scholar
• White CW, Avraham KB, Shanley PF, Groner Y. Transgenic mice with expression of elevated levels of copper–zinc superoxide dismutase in the lungs are resistant to pulmonary oxygen toxicity. J Clin Invest 1991; 87(6):2162–2168.
   PubMed Web of Science ®Google Scholar
• Chang LY, Kang BH, Slot JW, Vincent R, Crapo JD. Immunocytochemical localization of the sites of superoxide dismutase induction by hyperoxia in rat lungs. Lab Invest 1995; 73(1):29–39.
   PubMed Web of Science ®Google Scholar
• Wispe JR, Warner BB, Clark JC, Dey CR, Neuman J, Glasser SW, Crapo JD, Chang LY, Whitsett JA. Human Mn-superoxide dismutase in pulmonary epithelial cells of transgenic mice confers protection from oxygen injury. J Biol Chem 1992; 267(33):22937–22941.
   Google Scholar
• Harju T, Kaarteenaho-Wiik R, Sirvio R, Paakko P, Crapo JD, Oury TD, Shoini Y, Kinnula VL. Manganese superoxide dismutase is increased in the airways of smokers lungs. Eur Res J 2004; 24:765–771.
   PubMed Web of Science ®Google Scholar
• Oury TD, Chang LY, Marklund SL, Day BJ, Crapo JD. Immunocytochemical localization of extracellular superoxide dismutase in human lung. Lab Invest J Tech Meth Pathol 1994; 70:889–898.
   PubMed Web of Science ®Google Scholar
• Oury TD, Day BJ, Crapo JD. Extracellular superoxide dismutase in vessels and airways of humans and baboons. Free Radic Biol Med 1996; 20:957–965.
   PubMed Web of Science ®Google Scholar
• Gao F, Kinnula VL, Myllarniemi M, Oury TD. Extracellular superoxide dismutase in pulmonary fibrosis. Antioxid Redox Signal 2008; 10:343–354.
   PubMed Web of Science ®Google Scholar
• Reinhard C, Meyer B, Fuchs H, Stoeger T, Eder G, Ruschendorf F, Heyder J, Nurnberg P, De Angelis MH, Schulz H. Genomewide linkage analysis identifies novel genetic loci for lung function in mice. Am J Respir Crit Care Med 2005; 171:880–888.
   PubMed Web of Science ®Google Scholar
• Ganguly K, Stoeger T, Wesselkamper SC, Reinhard C, Sartor MA, Medvedovic M, Tomlinson CR, Bolle I, Mason JM, Leikauf GD, Schulz H. Candidate genes controlling pulmonary function in mice: transcript profiling and predicted protein structure. Physiol Genom 2007; 31:410–421.
   PubMed Web of Science ®Google Scholar
• Wilk JB, Walter RE, Laramie JM, Gottlieb DJ, O’Connor GT. Framingham Heart Study genome-wide associations: results for pulmonary function measures. BMC Med Genetics 2007; 8(Supp 1): S8.
   Google Scholar
• Young RP, Hopkins R, Black PN, Eddy C, Wu L, Gamble GD, Mills GD, Garret JE, Eaton TE, Rees MI. Functional variants of antioxidant genes in smokers with COPD and in those with normal lung function. Thorax 2006; 61:394–399.
   PubMed Web of Science ®Google Scholar
• Juul K, Tybjaerg-Hansen A, Marklund S, Lange P, Nordestgaard BG. Genetically increased antioxidative protection and decreased chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006; 173:858–864.
   PubMed Web of Science ®Google Scholar
• Harju T, Mazur W, Merikallio H, Soini Y, Kinnula VL. Glutathione-S-transferases in lung and sputum specimens, effects of smoking and COPD serverity. Respiratory Research 2008, 9:80, doi:10.1186/1465-9921-9-80.
   Google Scholar
• Joshi UM, Kodavanti PR, Mehendale HM. Glutathione metabolism and utilization of external thiols by cigarette smoke-challenge, isolated rat and rabbit lungs. Toxicol Appl Pharmacol 1988; 96:324–335.
   PubMed Web of Science ®Google Scholar
• Park EM, Park YM, Gwak YS. Oxidative damage in tissues of rats exposed to cigarette smoke. Free Radic Biol Med 1998; 25:79–86.
   PubMed Web of Science ®Google Scholar
• Cantin AM, North SL, Hubbard RC, Crystal RG. Normal alveolar epithelial lining fluid contains high levels of glutathione. J Appl Physiol 1987; 63:152–157.
   PubMed Web of Science ®Google Scholar
• Wang Y, Feinstein SI, Fisher AB. Peroxiredoxin 6 as an antioxidant enzyme protection of lung alveolar epithelial type II cells from HO-induced oxidative stress. J Cell Biochem 2008; 104:1274–1285.
   PubMed Web of Science ®Google Scholar
• Pak JH, Manevich Y, Kim HS, Feinstein SI, Fisher AB. An antisense oligonucleotide to 1-cys peroxiredoxin causes lipid peroxidation and apoptosis in lung epithelial cells. J Biol Chem 2002; 277:47729–49934.
   Google Scholar
• Wang Y, Manevich Y, Feinstein SI, Fisher AB. Adenovirus-mediated transfer of the 1-cys peroxiredoxin gene to mouse lung protects against hyperoxic injury. Am J Physiol Lung Cell Mol Physiol 2004; 286:L1188–L1193.
   PubMed Web of Science ®Google Scholar
• Wang Y, Phelan SA, Manevich Y, Feinstein SI, Fisher AB. Transgenic mice overexpressing peroxiredoxin 6 show increased resistance to lung injury in hyperoxia. Am J Respir Cell Mol Biol 2006; 34:481–486.
   PubMed Web of Science ®Google Scholar
• Rizvi SI, Maurya PK. Alterations in antioidant enzymes during aging in humans. Mol Biotechnol 2007; 37(1):58–61.
   PubMed Web of Science ®Google Scholar
• Moukdar F, Robidoux J, Lyght O, Pi J, Daniel KW, Collins S. Reduced antioxidant capacity and diet-induced atherosclerosis in uncoupling protein-2-deficient mice. J Lipid Res 2009; 50:59–70.
   PubMed Web of Science ®Google Scholar
• Inomata T, Betsuyaku T, Ito Y, Nasuhara Y, Nishimura M. Catalse expression in pulmonary macrophages of smokers and chronic obstructive pulmonary disease (COPD) patients. Amer J Respir Crit Care Med 2009; 179:A4157.
   Google Scholar
• Mak JCW, Ho SP, Yu WC, Choo KL, Chu CM, Yew WW, Lam WK, Chan-Yeung M. Polymorphisms and functional activity in superoxide dismutase and catalase genes in smokers with COPD. Eur Respir J 2007; 30:684–690.
   PubMed Web of Science ®Google Scholar
• Stocker R, Yamamoto Y, McDonagh AF, Glazer AN, Ames BN. Bilirubin is an antioxidant of possible physiological importance. Science 1987; 235:1043–1046.
   PubMed Web of Science ®Google Scholar
• Shinohara T, Kaneko T, Nagashima Y, Ueda A, Tagawa A, Ishigatsubo Y. Adenovirus-mediated transfer and overexpression of heme oxygenase 1 cNDNA in lungs attenuates elastase-induced pulmonary emphysema in mice. Hum Gene Ther 2005; 16:318–327.
   PubMed Web of Science ®Google Scholar
• Fredenburgh LE, Perrella MA, Mitsialis SA. The role of heme oxygenase-1 in pulmonary disease. Am J Respir Cell Mol Biol 2007; 36:158–165.
   PubMed Web of Science ®Google Scholar
• Choi BM, Pae HO, Jeong YR, Oh GS, Jun CD, Kim BR, Kim YM, Chung HT. Overexpression of heme oxygenase (HO)-1 renders Jurkat T cells resistant to fas-mediated apoptosis: involvement of iron released by HO-1. Free Radic Biol Med 2004; 36:858–871.
   PubMed Web of Science ®Google Scholar
• Sarady JK, Otterbein SL, Liu F, Otterbein LE, Choi AM. Carbon monoxidemodulates endotoxin-induced production of granulocyte macrophage colony-stimulating factor in macrophages. Am J Respir Cell Mol Biol 2002; 27:739–745.
   PubMed Web of Science ®Google Scholar
• Guenegou A, Leynaert B, Pin I, Le Moel G, Zureik M, Neukirch F. Serum carotenoids, vitamins A and E, 8 year lung function decline in a general population. Thorax 2006; 61(4):320–326.
   PubMed Web of Science ®Google Scholar
• Wu TC, Huang YC, Hsu SY, Wang YC, Yeh SL. Vitamin E and vitamin C supplementation in patients with chronic obstructive pulmonary disease. Int J Vitam Nutr Res 2007; 77(4):272–279.
   PubMed Web of Science ®Google Scholar
• Cotgreave IA. N-acetylcysteine: pharmacological considerations and experimental and clinical applications. Adv Pharmacol 1997; 38:205–227.
   PubMedGoogle Scholar
• Stav D, Raz M. Effect of N-acetylcysteine on airtrapping in COPD: a randomized placebo-controlled study. Chest 2009; 136(2):381–386.
   PubMed Web of Science ®Google Scholar
• Committee BTSR. Oral N-acetylcysteine and exacerbation rates in patients with chronic bronchitis and severe airways obstruction. Thorax 1985; 40(11):832–835.
   PubMed Web of Science ®Google Scholar
• Grassi C, Morandini GC. A controlled trial of intermittent oral acetylcysteine in the long-term treatment of chronic bronchitis. Eur J Clin Pharmacol 1976; 9(5–6):393–396.
   Web of Science ®Google Scholar
• Hansen NC, Skriver A, Brorsen-Riis L, Balslov S, Evald T, Maltbaek N, Gunnersen G, Garsdal P, Sander P, Pedersen JZ, Ibsen TB, Rasmussen FV. Orally administered N-acetylcysteine may improve general well-being in patietns with mild chronic bronchitis. Respir Med 1994; 88(7):531–535.
   PubMed Web of Science ®Google Scholar
• Schermer T, Chavannes N, Dekhuijzen R, Wouters E, Muris J, Akkermans R, van Schayck O, van Weel C. Fluticasone and N-acetylcysteine in primary care patietns with COPD or chronic bronchitis. Respir Med 2009; 103(4):542–551.
   PubMed Web of Science ®Google Scholar
• Decramer M, Rutten-van Molken M, Dekhuijzen PN, Troosters T, van Herwaarden C, Pellegrino R, van Schayck CP, Olivieri D, Del Donno M, De Backer W, Lankhorst I, Ardia A. Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randmoized on NAC Cost-Utility Study, BRONCUS): a randomized placebo-controlled trial. Lancet 2005; 365:1552–1560.
   PubMed Web of Science ®Google Scholar
• Schwartz J, Weiss ST. Dietary factors and their relation to respiratory symptoms. The second National Health and Nutrition Examination Survey. Am J Epidemiol 1990; 132:67–76.
   PubMed Web of Science ®Google Scholar
• Schwartz J, Weiss ST. Relationship between dietary vitamin C intake and pulmonary function in the first national health and nutrition examination survey (NHANES I). Am J Clin Nutr 1994; 59:110–114.
   PubMed Web of Science ®Google Scholar
• Hu G, Cassano PA. Antioxidant nutrients and pulmonary function: the Third National Health and Nutrition Examination Survey (NHANES III). Am J Epidemiol 2000; 151:975–981.
   PubMed Web of Science ®Google Scholar
• Tabak C, Feskens EJ, Heederik D, Kromhout D, Menotti A, Blackburn HW. Fruit and fish consumption: a possible explanation for population differences in COPD mortality (The Seven Countries Study). Eur J Clin Nutr 1998; 52:819–825.
   PubMed Web of Science ®Google Scholar
• Tabak C, Smit HA, Heederik D, Ocke MC, Kromhout D. Diet and chronic obstructive pulmonary disease: inderdependent beneficial effects of fruits, whole grains and alcohol (the MORGAN Study). Clin Exp Allergy 2001; 31:747–755.
   PubMed Web of Science ®Google Scholar
• Miedema I, Feskens EJ, Heederik D, Kromhout D. Dietary determinants of long-term incidence of chronic non-specific lung disease: The Zutphen Study. Am J Epidemiol 1993; 138:37–45.
   PubMed Web of Science ®Google Scholar
• Gilks CB, Price K, Wright JL, Churg A. Antioxidant gene expression in rat lung after exposure to cigarette smoke. Am J Pathology 1998; 152:269–278.
   PubMed Web of Science ®Google Scholar
• Tager M, Piecyk A, Kohnlein T, Thiel U, Ansorge S, Welte T. Evidence of a defective thiol status of alveolar macrophages from COPD patients and smokers: chronic obstructive pulmonary disease. Free Radic Biol Med 2000; 29(11):1160–1165.
   PubMedGoogle Scholar
• Rahman I, Morrison D, Donaldson K, MacNee W. Systemic oxidative stress in asthma, COPD and smokers. Am J Respir Crit Care Med 1996; 154(4 pt 1):1055–1060.
   PubMed Web of Science ®Google Scholar
• Celli BR, Barnes PJ. Exacerbations of chronic obstructive pulmonary disease. Eur Respir J 2007; 29:1224–1238.
   PubMed Web of Science ®Google Scholar
• Varkey JB, Varkey B. Viral infections in patients with chronic obstrutive pulmonary disease. Curr Opin Pulm Med 2008; 14:89–94.
   PubMed Web of Science ®Google Scholar
• Novel Swine-Origin Influenza A (H1N1) Virus Investiation Team. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 2009; 360:2605–2615.
   PubMed Web of Science ®Google Scholar
• Hansel TT, Barnes PJ. New drugs for exacerbations of chronic obstructive pulmonary disease. Lancet 2009; 374:744–755.
   PubMed Web of Science ®Google Scholar
• Biernacki WA, Kharitonov SA, Barnes PJ. Increased leukotriene B4 and 8-isoprostane in exhaled breath condensate of patients with exacerbation of COPD. Thorax 2003; 58(4):294–298.
   PubMed Web of Science ®Google Scholar
• Drost EM, Ritchie HE, Skwarska E. NF-κB activation in airway leucocytes in COPD patients. Eur Res J 2001; 160:260s.
   Google Scholar
• Nishikawa M, Kakemizu N, Ito T, Kudo M, Kaneko T, Suzuki M, Udaka N, Ikeda H, Okubo T. Superoxide mediates cigarette smoke-induced infiltration of neutrophils into the airways through nuclear factor-kappaB activation and IL-8 mRNA expression in guinea pigs in vivo. Am J Respir Cell Mol Biol 1999; 20:189–198.
   PubMed Web of Science ®Google Scholar
• Tuder RM, Zhen L, Cho CY, Taraseviciene-Stewart L, Kasahara Y, Salvemini D, Voelkel NF, Flores SC. Oxidative stress and apoptosis interact and cause emphysema due to vascular endothelial growth factor receptor blockade. Am J Respir Cell Mol Biol 2003; 29:88–97.
   PubMed Web of Science ®Google Scholar
• Hirayama F, Lee AH, Binns CW, Zhao Y, Hiramatsu T, Tanikawa Y, Nishimura K, Taniguchi H. Do vegetables and fruits reduce the risk of chronic obstructive pulmonary disease? A case–control study in Japan. Prev Med 2009; 49(2–3):184–189.
   PubMed Web of Science ®Google Scholar
• Sutherland ER, Crapo JD, Bowler RP. N-acetylcysteine and exacerbations of chronic obstructive pulmonary disease. J COPD 2006; 3(4):195–202.
   PubMedGoogle Scholar
• Zuin R, Palamidese A, Negrin R, Catozzo L, Scarda A, Balbinot M. High-dose N-acetylcysteine in patietns with exacerbations of chronic obstructive pulmonary disease. Clin Drug Investig 2005; 25(6):401–408.
   PubMed Web of Science ®Google Scholar
• Epperly MW, Defilippi S, Sikora C, Gretton J, Kalend A, Greenberger JS. Intractracheal injection of manganese superoxide dismutase (MnSOD) plasmid/liposomes protects normal lung but not orthotopic tumors from irradiation. Gene Therapy 2000; 7:1011–1018.
   PubMed Web of Science ®Google Scholar
• Griese M, Ramakers J, Krasselt A, Starosta V, Van Koningsbruggen S, Fischer R, Ratjen F, Müllinger B, Huber RM, Maier K, Rietschel E, Scheuch G. Improvement of alveolar glutathione and lung function but not oxidative state in cystic fibrosis. Am J Respir Crit Care Med 2004; 169:822–828.
   PubMed Web of Science ®Google Scholar
• Bishop C, Hudson VM, Hilton SC, Wild C. A pilot study of the effect of inhaled buffered glutathione on the clinical status of patients with cystic fibrosis. Chest 2005; 127:308–317.
   PubMed Web of Science ®Google Scholar
• MacNee W, Rahman I. Oxidants/antioxidants in idiopathic pulmonary fibrosis. Thorax 1995; 50(Supp 1):S53–S58.
   PubMedGoogle Scholar
• Borok Z, Buhl R, Grimes GJ, Bokser AD, Hubbard RC, Holroyd KJ, Roum JH, Czerski DB, Cantin AM, Crystal RG. Effect of glutathione aerosol on oxidant-antioxidant imbalance in idiopathic pulmonary fibrosis. Lancet 1991; 338(8761):215–216.
   PubMed Web of Science ®Google Scholar
• Gillissen A, Jaworska M, Orth M, Coffiner M, Maes P, App EM, Cantin AM, Schultze-Werninghaus G. Nacystelyn, a novel lysine salt of N-acetylcysteine, to augment cellular antioxidant defence in vitro. Respir Med 1997; 91:159–168.
   PubMed Web of Science ®Google Scholar
• Mao JT, Tashkin DP, Belloni PN, Baileyhealy I, Baratelli F, Roth MD. All-trans retinoic acid modulates the balance of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in patients with emphysema. Chest 2003; 125(4):1724–1732.
   Google Scholar
• Calverley PM, Sanchez-Toril F, McIvor A, Teichmann P, Bredenbroeker D, Fabbri LM. Effect of 1-year treatment with roflumilast in severe chronic obstructive pulmonary disease. Am J Respir Care Med 2007; 176(2):154–161.
   PubMed Web of Science ®Google Scholar
• Vestbo J, Tan L, Atkinson G, Ward J. and on behalf of the UK-500,001 Global Study Team. A controlled trial of 6-weeks’ treatment with a novel inhaled phophodiesterase type-4 inhibitor in COPD. Eur Respir J 2009; 33(5):1039–1044.
   PubMed Web of Science ®Google Scholar
• Mutlu GM, Garey KW, Robbins RA, Danziger LH, Rubinstein I. Collection and analysis of exhaled breath condensate in humans. Am J Respir Crit Care Med 2001; 164:731–737.
   PubMed Web of Science ®Google Scholar
• Montuschi P. Review: analysis of exhaled breath condensate in respiratory medicine: methodological aspects and potential clinical applications. Ther Adv Res Dis 2007; 1:5–23.
   PubMedGoogle Scholar
• Liu J, Thomas PS. Exhaled breath condensate as a method of sampling airway nitric oxide and other markers of inflammation. Med Sci Monit 2005; 11(8):MT53–MT62.
   PubMed Web of Science ®Google Scholar
• Kharitonov SA, Barnes PJ. Exhaled Biomarkers. Chest 2006; 131:1541–1546.
   Google Scholar
• Liu J, Conrad DH, Chow S, Tran VH, Yates DH, Thomas PS. Collection devices influence the constituents of exhaled breath condensate. Eur Respir J 2007; 30:807–808.
   PubMed Web of Science ®Google Scholar
• Silkoff PE, Erzurum SC, Lundberg JO, George SC, Marczin N, Hunt JF, Effros R, Horvath I. ATS Workshop Proceedings: exhaled nitric oxide and nitric oxide oxidative metabolism in exhaled breath condensate. Proc Am Thorac Soc 2006; 3(2):131–145.
   PubMedGoogle Scholar
• Chow S, Yates DH, Thomas PS. Reproducibility of exhaled breath condensate markers. Eur Respir J 2008; 32(4):1124–1126.
   PubMed Web of Science ®Google Scholar
• Lee W, Thomas PS. Oxidative stress in COPD and its measurement through exhaled breath condensate. Clin Transl Sci 2009; 2(2):150–155.
   PubMed Web of Science ®Google Scholar
• Dahl M, Bowler RP, Juul K, Crapo JD, Levy S, Nordestgaard BG. Superoxide dismutase 3 polymorphism associated with reduced lung function in two large population. Amer J Respir Crit Care Med 2008; 178(9):906–912.
   PubMed Web of Science ®Google Scholar
• Arcaroli JJ, Hokanson JE, Abraham E, Geraci M, Murphy JR, Bowler RP, Dinarello CA, Silveira L, Sankoff J, Heyland D, Wischmeyer P, Crapo JD. Extracellular superoxide dismutase haplotypes are associated with acute lung injury and mortality. Amer J Respir Crit Care Med 2009; 179:105–112.
   PubMed Web of Science ®Google Scholar
• Sagiura H, Ichikawa T, Liu X, Kobayashi T, Wang XQ, Kawasaki S, Togo S, Kamio K, Mao L, Ann Y, Ichinose M, Rennard SI. N-acetyl-l-cysteine inhibits TGF-beta(1)-induced profibrotic response in fibroblasts. Pulm Pharmacol Ther 2009; 22(6):487–491.
   PubMed Web of Science ®Google Scholar
• Decramer M, Dekhuijzen PNR, Troosters T, Van Herwaarden C, Rutten-Van Molken M, Van Schayck CPO, Olivieri D, Lankhorst I, Ardia A. The Bronchitis Randomized on NAC Cost-Utility Study (BRONCUS): hypothesis and design. Eur Res J 2001; 17:329–336.
   PubMed Web of Science ®Google Scholar
• Kirkil G, Hamdi Muz M, Seckin D, Sahin K, Kucuk O. Antioxidant effect of zinc picolinate in patietns with chronic obstructive pulmonary disease. Respir Med 2008; 102(6):840–844.
   PubMed Web of Science ®Google Scholar
• Nadeem A, Raj HG, Chhabra SK. Effect of vitamin E supplementation with standard treatment on oxidant–antioxidant status in chronic obstructive pulmonary disease. Indian J Med Res 2008; 128(6):705–711.
   PubMed Web of Science ®Google Scholar
• Conklin JD, Trinity JD, Amann M, Fjeldstad A, Wray DW, Richardson RS. Antioxidant supplementation improves oxygen delivery and blood flow to exercising skeletal muscle in COPD. Amer J Respir Crit Care Med 2010; 181:A6842.
   Web of Science ®Google Scholar